Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.5, 2013-05, pp. : 467-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ongoing Clinical Trials in Prostate Cancer: The STAMPEDE Trial

Oncology Research and Treatment, Vol. 39, Iss. 7-8, 2016-07 ,pp. : 464-467

Karger

Access to resources Recommend Favorite

Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials

By Singh Nishith Madan Ravi Gulley James L

Clinical Investigation, Vol. 3, Iss. 7, 2013-07 ,pp. : 651-663

Future Science

Access to resources Recommend Favorite

Comorbidity as a Focus of Clinical Cancer Trials: An Important Unmet Need

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 279-280

Karger

Access to resources Recommend Favorite

Geography: an increasingly important variable in prostate cancer clinical trials

BJU INTERNATIONAL, Vol. 115, Iss. 1, 2015-01 ,pp. : 2-3

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen

Reviews on Recent Clinical Trials, Vol. 2, Iss. 3, 2007-09 ,pp. : 182-190

Bentham Science Publishers

Access to resources Recommend Favorite